Published on 26 Oct 2023 on Benzinga
Sonnet BioTherapeutics Holdings, Inc. SONN shares are trading lower by 8.5% to $1.18 Thursday morning on downward momentum. The company this week announced pricing of a public offering involving 2,843,750 shares of common stock or pre-funded warrants, along with investor warrants allowing the purchase of up to 5,687,500 shares of common stock.
What Else?